O
Olivier Barthelemy
Researcher at University of Paris
Publications - 100
Citations - 8347
Olivier Barthelemy is an academic researcher from University of Paris. The author has contributed to research in topics: Percutaneous coronary intervention & Myocardial infarction. The author has an hindex of 29, co-authored 92 publications receiving 5728 citations. Previous affiliations of Olivier Barthelemy include Leipzig University & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet,Holger Thiele,Emanuele Barbato,Olivier Barthelemy,Johann Bauersachs,Deepak L. Bhatt,Paul Dendale,Maria Dorobantu,Thor Edvardsen,Thierry Folliguet,Chris P Gale,Martine Gilard,Alexander Jobs,Peter Jüni,Ekaterini Lambrinou,Basil S. Lewis,Julinda Mehilli,Emanuele Meliga,Béla Merkely,Christian Mueller,Marco Roffi,Frans H. Rutten,Dirk Sibbing,George C.M. Siontis +23 more
TL;DR: A correction has been published: European Heart Journal, ehaa895, https://doi.org/10.1093/eurheartj/ehaa-895.
Journal ArticleDOI
Bedside monitoring to adjust antiplatelet therapy for coronary stenting.
Jean-Philippe Collet,Thomas Cuisset,Grégoire Rangé,Guillaume Cayla,Simon Elhadad,Christophe Pouillot,Patrick Henry,Pascal Motreff,Didier Carrié,Ziad Boueri,Loic Belle,Eric Van Belle,Hélène Rousseau,Pierre Aubry,Jacques Monsegu,Pierre Sabouret,Jérémie Abtan,Mathieu Kerneis,Christophe Saint-Etienne,Olivier Barthelemy,Farzin Beygui,Johanne Silvain,Eric Vicaut,Gilles Montalescot +23 more
TL;DR: This study showed no significant improvements in clinical outcomes with platelet-function monitoring and treatment adjustment for coronary stenting, as compared with standard antiplatelet therapy without monitoring.
Journal ArticleDOI
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock
Holger Thiele,Ibrahim Akin,Marcus Sandri,Georg Fuernau,Suzanne de Waha,Roza Meyer-Saraei,Peter Nordbeck,Tobias Geisler,Ulf Landmesser,Carsten Skurk,Andreas Fach,Harald Lapp,Jan J. Piek,Marko Noc,Tomaž Goslar,Stephan B. Felix,Lars S. Maier,Janina Stępińska,Keith G. Oldroyd,Pranas Šerpytis,Gilles Montalescot,Olivier Barthelemy,Kurt Huber,Stephan Windecker,Stefano Savonitto,Patrizia Torremante,Christiaan J. Vrints,Steffen Schneider,Steffen Desch,Uwe Zeymer +29 more
TL;DR: Among patients who had multivessel coronary artery disease and acute myocardial infarction with cardiogenic shock, the 30‐day risk of a composite of death or severe renal failure leading to renal‐replacement therapy was lower among those who initially underwent PCI of the culprit lesion only than amongThose who underwent immediate multivessels PCI.
Journal ArticleDOI
Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration: A Systematic Meta-Analysis
Jean-Sébastien Hulot,Jean-Philippe Collet,Johanne Silvain,Ana Pena,Anne Bellemain-Appaix,Olivier Barthelemy,Guillaume Cayla,Farzin Beygui,Gilles Montalescot +8 more
TL;DR: In this paper, a meta-analysis was performed on 23 studies using the odds ratio (OR) as the parameter of efficacy, with a fixed-effect model, to assess the association between the loss-of-function cytochrome P450 2C19 (CYP2C19)*2 variant (10 studies, 11,959 patients) or the use of proton pump inhibitors (PPIs) in patients treated with clopidogrel.
Journal ArticleDOI
Composition of coronary thrombus in acute myocardial infarction.
Johanne Silvain,Jean-Philippe Collet,Chandrasekaran Nagaswami,Farzin Beygui,Kathryn E. Edmondson,Anne Bellemain-Appaix,Guillaume Cayla,Ana Pena,Delphine Brugier,Olivier Barthelemy,Gilles Montalescot,John W. Weisel +11 more
TL;DR: In acute STEMI, platelet and fibrin contents of the occlusive thrombus are highly dependent on ischemia time, which may have a direct impact on the efficacy of drugs or devices used for coronary reperfusion.